Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cetirizine dihydrochloride
Cat. No.:
OB0225LY-0105
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Cetirizine dihydrochloride is a second-generation antihistamine that is less likely to cause drowsiness and has an anti-allergic effect.
Synonym:
P071; UCB P071; Cetirizine DiHCl; 83881-52-1; 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride; (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid dihydrochloride; [2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride; 2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride
CAS No.:
83881-52-1
Compound CID:
55182
Formula:
C21H27Cl3N2O3
Formula Weight:
461.81
Specification
Relative Density:
0.932 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Cetirizine dihydrochloride is mainly used in drug development e.g. to relieve allergic rhinitis and chronic urticaria.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
c8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 119.1 mM
Water Max Solubility:
46.2 mg/mL; 100 mM
